Aptinyx

YTD

ALL

Why Robinhood?

You can watch Aptinyx and buy or sell other stocks, ETFs, and their options commission-free!

About APTX

Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication.

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

—

Employees—

Headquarters

Evanston, Illinois

HeadquartersEvanston, Illinois

Founded

2015

Founded2015

Employees

—

Employees—

APTX Key Statistics

Market cap

6.50M

Market cap6.50M

Price-Earnings ratio

-0.10

Price-Earnings ratio-0.10

Dividend yield

—

Dividend yield—

Average volume

536.11K

Average volume536.11K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.72

52 Week high$0.72

52 Week low

$0.009

52 Week low$0.009

People also own

Based on the portfolios of people who own APTX. This list is generated using Robinhood data, and it’s not a recommendation.